How Digital Therapeutics Are Reshaping Chronic Care | Brillio

Chronic diseases such as diabetes, heart disease, and hypertension remain the leading drivers of poor health outcomes and rising healthcare costs in the U.S. Yet, the traditional model of chronic care is outdated, fragmented, and reactive-leaving patients without the continuous support they need.

In her feature article for Healthcare Business Today, Avantika Sharma highlights how digital therapeutics (DTx) are transforming this landscape. Unlike generic health apps, DTx are clinically validated, software-based interventions that provide real-time monitoring, AI-driven personalization, and behavioral reinforcement to help patients manage chronic conditions more effectively. By integrating into clinical workflows, DTx empower providers to act proactively rather than reactively, closing gaps in care.

While regulatory, reimbursement, and access barriers remain, Avantika emphasizes that hybrid models combining AI and DTx hold the potential to deliver patient-centered, proactive, and seamless chronic care at scale.

Let's Build a Smarter, Superior,
Sustainable Tomorrow